Anti-SARS-CoV-2 nsp12 Polyclonal Antibody

2'-O-methyltransferase nsp16, 3C-like proteinase nsp5, 3CL-PRO, 3CLp, EC:2.1.1.56, EC:2.1.1.57, EC:2.7.7.48, EC:2.7.7.50, EC:3.1.13.-, EC:3.4.19.12, EC:3.4.22.-, EC:3.4.22.69, EC:3.6.4.12, EC:3.6.4.13, EC:4.6.1.-, ExoN, GFL, Growth factor-like peptide, Guanine-N7 methyltransferase nsp14, Hel, Helicase nsp13, Host translation inhibitor nsp1, Leader protein, Main protease, Mpro, NendoU, Non-structural protein 1, Non-structural protein 10, Non-structural protein 12, Non-structural protein 13, Non-structural protein 14, Non-structural protein 15, Non-structural protein 16, Non-structural protein 2, Non-structural protein 3, Non-structural protein 4, Non-structural protein 5, Non-structural protein 6, Non-structural protein 7, Non-structural protein 8, Non-structural protein 9, ORF1ab polyprotein, PL-PRO, PL2-PRO, Papain-like protease nsp3, Papain-like proteinase, Pol, Proofreading exoribonuclease nsp14, RNA-capping enzyme subunit nsp9, RNA-directed RNA polymerase nsp12, RdRp, Replicase polyprotein 1ab, SARS coronavirus main proteinase, Uridylate-specific endoribonuclease nsp15, Viral protein genome-linked nsp9, nsp1, nsp10, nsp12, nsp13, nsp14, nsp15, nsp16, nsp2, nsp3, nsp4, nsp5, nsp6, nsp7, nsp8, nsp9, p65 homolog, pp1ab, rep

Bat coronavirus Rp3/2004, Bat coronavirus 279/2005, Severe acute respiratory syndrome coronavirus 2, Bat coronavirus HKU3, Severe acute respiratory syndrome coronavirus